Synaptogenix, Inc. – NASDAQ:SNPX
Synaptogenix stock price today
$7.92
+4.64
+141.46%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Synaptogenix stock price monthly change
-27.27%
month
Synaptogenix stock price quarterly change
-27.27%
quarter
Synaptogenix stock price yearly change
+1042.86%
year
Synaptogenix key metrics
Market Cap | 4.20M |
Enterprise value | N/A |
P/E | -1.09 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.18 |
PEG ratio | N/A |
EPS | -1.71 |
Revenue | N/A |
EBITDA | -6.02M |
Income | -4.53M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSynaptogenix stock price history
Synaptogenix stock forecast
Synaptogenix financial statements
| Jun 2023 | 0 | -4.09M | |
|---|---|---|---|
| Sep 2023 | 0 | 763.20K | |
| Dec 2023 | 10.27K | -995.96K | -9694.07% |
| Mar 2024 | 0 | -206.69K |
| 2027 | 0 | -31.22M |
|---|
Analysts Price target
Financials & Ratios estimates
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | 10.6% |
| 2021 | |
| 2022 | 0.06% |
| 2023 | 20.23% |
| Jun 2023 | 33437165 | 6.52M | 19.53% |
|---|---|---|---|
| Sep 2023 | 32360458 | 3.93M | 12.15% |
| Dec 2023 | 31113667 | 5.52M | 17.77% |
| Mar 2024 | 29399248 | 6.52M | 22.19% |
| Jun 2023 | -1.23M | -669 | -1.64M |
|---|---|---|---|
| Sep 2023 | -1.17M | 0 | 49 |
| Dec 2023 | -1.06M | -2M | -51 |
| Mar 2024 | -1.83M | -500K | 0 |
Synaptogenix alternative data
| Aug 2023 | 5 |
|---|---|
| Sep 2023 | 5 |
| Oct 2023 | 5 |
| Nov 2023 | 5 |
| Dec 2023 | 5 |
| Jan 2024 | 5 |
| Feb 2024 | 5 |
| Mar 2024 | 5 |
| Apr 2024 | 5 |
| May 2024 | 5 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Synaptogenix other data
2.04%
-4.28%
of SNPX is owned by hedge funds
142.52K
-299.26K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 0 | 162450 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | SINGER WILLIAM S. director | Common Stock, par value $0.0001 per share | 27,000 | $1.17 | $31,644 | ||
Sale | WEINSTEIN ROBERT officer: Chief Fi.. | Common Stock, par value $0.0001 per share | 27,000 | $1.17 | $31,644 | ||
Sale | SILVERMAN JOSHUA director | Common Stock, par value $0.0001 per share | 19,012 | $1.17 | $22,282 | ||
Sale | SCHECHTER JONATHAN director | Common Stock, par value $0.0001 per share | 20,250 | $1.17 | $23,733 | ||
Sale | ALKON DANIEL L. officer: President and CSO | Common Stock, par value $0.0001 per share | 19,688 | $1.17 | $23,074 | ||
Sale | BERNSTEIN BRUCE director | Common Stock, par value $0.0001 per share | 22,500 | $1.17 | $26,370 | ||
Sale | TUCHMAN ALAN J officer: Chief Executive Officer | Common Stock, par value $0.0001 per share | 27,000 | $1.17 | $31,644 | ||
Purchase | SILVERMAN JOSHUA director | Common Stock, par value $0.0001 per share | 10,000 | $8.3 | $83,000 | ||
Purchase | ALKON DANIEL L. director, officer: Chief Scient.. | Common Stock, par value $0.0001 per share | 10,000 | $8.26 | $82,600 |
-
What's the price of Synaptogenix stock today?
One share of Synaptogenix stock can currently be purchased for approximately $7.92.
-
When is Synaptogenix's next earnings date?
Unfortunately, Synaptogenix's (SNPX) next earnings date is currently unknown.
-
Does Synaptogenix pay dividends?
No, Synaptogenix does not pay dividends.
-
How much money does Synaptogenix make?
Synaptogenix has a market capitalization of 4.20M.
-
What is Synaptogenix's stock symbol?
Synaptogenix, Inc. is traded on the NASDAQ under the ticker symbol "SNPX".
-
What is Synaptogenix's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Synaptogenix?
Shares of Synaptogenix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Synaptogenix have?
As Jul 2024, Synaptogenix employs 5 workers.
-
When Synaptogenix went public?
Synaptogenix, Inc. is publicly traded company for more then 4 years since IPO on 8 Dec 2020.
-
What is Synaptogenix's official website?
The official website for Synaptogenix is synaptogen.com.
-
Where are Synaptogenix's headquarters?
Synaptogenix is headquartered at 1185 Avenue of the Americas, New York, NY.
-
How can i contact Synaptogenix?
Synaptogenix's mailing address is 1185 Avenue of the Americas, New York, NY and company can be reached via phone at +973 2420005.
Synaptogenix company profile:
Synaptogenix, Inc.
synaptogen.comExchange:
NASDAQ
Full time employees:
5
Industry:
Biotechnology
Sector:
Healthcare
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.
1185 Avenue of the Americas
New York, NY 10036
New York, NY 10036
CIK: 0001571934
ISIN: US87167T2015
CUSIP: 87167T201
